The optimism lasted exactly one month. In February, the Massachusetts Business Confidence Index had crossed the line separating pessimism from optimism for the first time in a year—a small but significant respite for the state’s employers after months of mounting uncertainty. In March, that relief vanished. The AIM Business Confidence Index, the longest-running barometer of […]
Cambridge-based Biogen announced it will acquire Apellis Pharmaceuticals, headquartered in Waltham, in an all-cash deal worth approximately $5.6 billion — or $41 per share. When Apellis stock closed on Monday, it was trading at roughly half that. By Tuesday morning, shares had more than doubled overnight. That kind of move tells you something about what
There is a pattern worth naming here. In 2024, Takeda announced a major restructuring that cut hundreds of Massachusetts jobs. In 2025, the Japanese pharmaceutical giant eliminated more Cambridge positions after shutting down its cell therapy program entirely. And this week, the company filed a WARN Act notice with the state of Massachusetts confirming that
Takeda Is Cutting 250 Jobs in Cambridge. It’s the Third Time in Two Years Read More »
There is a 14-story office building at 1 State Street, in the heart of Boston’s Financial District, that has been quietly emptying out for years. It sits one block from Faneuil Hall, two blocks from the waterfront, steps from three MBTA lines. By almost any measure, it is exactly where people should want to live.
Boston’s Empty Office Buildings Are Becoming Apartments. 1 State Street Is Next Read More »
Fifty million dollars is a serious amount of money for a company that started as a vaccine project in Harvard’s Innovation Lab. But then again, Ozempic is a serious amount of market — and Terrestrial Bio, the Boston-based company that just closed a $50 million Series C round, is betting it has figured out something
Something unexpected happened in the middle of 2025. While the Trump administration was cutting $27 billion from federal rental assistance programs and proposing the elimination of the Department of Housing and Urban Development as most people know it, Congress quietly did something that developers of affordable housing had been waiting years for: it made the
The Federal Tax Credit That’s Sending Boston Developers Back to the Drawing Board Read More »
There is a six-acre stretch of land in South Boston, sitting between two Red Line stations, with approved permits for a 1.1-million-square-foot life sciences campus across the street. By almost any measure, it should be one of the most valuable undeveloped parcels in the city. On March 17, it went to foreclosure auction. The property
A $75 Million Bet on South Boston Just Went to Foreclosure Auction Read More »
Thirty years is a long time to build something. VentureWell — the Massachusetts-based nonprofit that has funded, trained, and connected tens of thousands of science and technology entrepreneurs since 1995 — announced this week it is shutting down. The organization that helped launch student-founded companies across nearly 400 universities, that put $7 billion in investor
VentureWell Is Closing: It Took 30 Years to Build and a Stop-Work Order to End Read More »
For months, it was one of the worst-kept secrets in Boston’s commercial real estate market. JPMorgan Chase had been quietly scouting a location to consolidate its four scattered downtown offices into a single, unified headquarters. The building everyone expected them to choose was South Station Tower — the 51-story glass skyscraper that opened last September
JPMorgan Is Moving Into Boston’s Tallest New Skyscraper Read More »
Every March, Austin, Texas becomes the temporary capital of the global startup world. South by Southwest draws thousands of founders, investors, and technology executives from more than 100 countries, and the SXSW Pitch competition — now in its 18th year — has become one of the most watched startup showcases on the planet. Since 2009,
This Boston Startup Just Won One of the Most Competitive Pitch Competitions in the World Read More »
